FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tony Shu Kam Mok

Research Profile

Disorders

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Physiology

Mutation

Geographic Areas

Hong Kong

Co-author Network

Publications

TOP 3
Corey J Langer; Tony Shu Kam Mok; Pieter E Postmus
Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC).
Tony Shu Kam Mok; Jin-Ji Yang; Kwok-Chi Lam
Treating patients with EGFR-sensitizing mutations: first line or second line--is there a difference?
Fred R Hirsch; Pasi A Janne; Edward S Kim; Tetsuya Mitsudomi; Myung-Ju Ahn; Federico Cappuzzo; Hak Choy; Wilfried E Eberhardt; David R Gandara; Luis Paz-Ares; Robert Pirker; Frances A Shepherd; Nick Thatcher; Yi-Long Wu; Tony Shu Kam Mok
Epidermal growth factor receptor inhibition in lung cancer: status 2012.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tony Shu Kam Mok (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Corey J Langer; Tony Shu Kam Mok; Pieter E Postmus
Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC).
Cancer treatment reviews 2013;39(3):252-60.
2013: Tony Shu Kam Mok; Jin-Ji Yang; Kwok-Chi Lam
Treating patients with EGFR-sensitizing mutations: first line or second line--is there a difference?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(8):1081-8.
2013: Fred R Hirsch; Pasi A Janne; Edward S Kim; Tetsuya Mitsudomi; Myung-Ju Ahn; Federico Cappuzzo; Hak Choy; Wilfried E Eberhardt; David R Gandara; Luis Paz-Ares; Robert Pirker; Frances A Shepherd; Nick Thatcher; Yi-Long Wu; Tony Shu Kam Mok
Epidermal growth factor receptor inhibition in lung cancer: status 2012.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(3):373-84.
2012: Linda Leung; Kwok Chi Lam; Tony Shu Kam Mok
Non-small cell lung cancer: One size doesn't fit all.
Asia-Pacific journal of clinical oncology 2012;8(3):211-2.
2012: Yi-Long Wu; Li Zhang; Caicum Zhou; Da-Tong Chu; Emma Duffield; Baohui Han; Haiyi Jiang; Meilin Liao; Xuyi Liu; Tony Shu Kam Mok; Masahiro Fukuoka
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China.
Asia-Pacific journal of clinical oncology 2012;8(3):232-43.
2012: Stephen L Chan; Edwin P Hui; Linda K S Leung; Brigette B Y Ma; Frankie K F Mo; Tony Shu Kam Mok; Cesar S C Wong; Anthony T C Chan; Charles M L Chan; Winnie Yeo
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
Cancer 2012;118(16):3984-92.
2012: Jean-Charles Soria; Tony Shu Kam Mok; Federico Cappuzzo; Pasi A Janne
EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospects.
Cancer treatment reviews 2012;38(5):416-30.
2012: Linda Leung; Tony Shu Kam Mok; Herbert Loong
Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer.
Therapeutic advances in medical oncology 2012;4(4):173-81.
2012: Paul Mitchell; Tony Shu Kam Mok; Alena Strizek; Helen Barraclough; Rebecca Lew; Maximiliano van Kooten
Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review.
Clinical lung cancer 2012;13(4):239-51.
2012: Tony Shu Kam Mok; Manolo D'arcangelo; Raffaele Califano
Clinical outcomes with erlotinib in patients with epidermal growth factor receptor mutation.
Drugs 2012;72 Suppl 1():3-10.
2012: Stephen L Chan; Tony Shu Kam Mok; Brigette B Y Ma
Management of hepatocellular carcinoma: beyond sorafenib.
Current oncology reports 2012;14(3):257-66.
2012: Ross Soo; Byoung-Chul Cho; Tomoya Kawaguchi; Marie Loh; Tony Shu Kam Mok; Sai-Hong I Ou; Marie P Shieh; Richie Soong
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy.
Future oncology (London, England) 2012;8(4):451-62.
2012: GILBERTO LOPES; Young K Do; Tony Shu Kam Mok; Joel E Segel; Daniel S W Tan; Eric A Finkelstein
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung.
Cancer 2012;118(4):1032-9.
2012: Stephen L Chan; Frankie K F Mo; Grace L H Wong; Tony Shu Kam Mok; Herbert H F Loong; Vicky T C Chan; Vincent W S Wong; Winnie Yeo; Giok S Liem; Anthony T C Chan; Darren M C Poon; Henry L Y Chan
Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(2):271-8.
2012: George P Kim; Philip A Philip; Michelle R Mahoney; Robert Marshke; Kyle Holen; Daniel Szydlo; Joel Picus; Tony Shu Kam Mok; Joseph Rubin; Michael Boyer; John J Wright; Anna Nowak; Henry C Pitot; Charles Erlichman
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.
Investigational new drugs 2012;30(1):387-94.
2012: She-Juan An; Zhi-Hong Chen; Ji-Lin Guan; Ling Huang; Tony Shu Kam Mok; Qiang Nie; Jian Su; Hong-Hong Yan; Jin-Ji Yang; Xue-Ning Yang; Xu-Chao Zhang; Wen-Zhao Zhong; Qing Zhou; Yi-Long Wu
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.
PloS one 2012;7(6):e40109.
2012: Zhi-Yong Chen; Ben-Yuan Jiang; Tony Shu Kam Mok; Jian Su; Hong-Hong Yan; Jin-Ji Yang; Xue-Ning Yang; Xu-Chao Zhang; Wen-Zhao Zhong; Qing Zhou; She-Juan An; Hua-Jun Chen; Zhi-Hong Chen; Yi-Long Wu
EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.
The oncologist 2012;17(7):978-85.
2012: Koichi Goto; Nobuyuki Yamamoto; Yukito Ichinose; Yuichiro Ohe; Emma Duffield; Kazuto Nishio; Tony Shu Kam Mok; Shunichi Negoro; Haiyi Jiang; Nagahiro Saijo; Rose McCormack; Yohji Itoh; Masahiro Fukuoka
Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(1):115-21.
2011: Vivian Wai Yan Lui; Margaret Heung Ling Ng; Chi Man Tsang; Sai Wah Tsao; Anthony Tc Chan; Suk-Hang Cheng; Kakiu Ho; Cecilia Pik Yuk Lau; Kenny Ieng Kit Lei; Tony Shu Kam Mok
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.
Investigational new drugs 2011;29(6):1241-52.
2011: Tony Shu Kam Mok
Personalized medicine in lung cancer: what we need to know.
Nature reviews. Clinical oncology 2011;8(11):661-8.
2011: Edwin P Hui; Maria Lai; Kenny I K Lei; Linda K S Leung; Ada T W Ma; Brigette B Y Ma; Suzanne S S Mak; Frankie Mo; Tony Shu Kam Mok; Annette Poon; Terence C W Poon; Winnie Yeo; Benny C Y Zee; Vicky T C Chan; Eadaoin K P Hui; Anthony T C Chan
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(10):1625-35.
2011: G R Blumenschein; Y-J Hei; Fairooz Kabbinavar; K Kracht; K Lakshmaiah; H Menon; Tony Shu Kam Mok; Karen Reckamp; L Schwartzberg; R Sikorski; J Stephenson; Y-N Sun; J T Beck
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2057-67.
2011: Carmen W H Chan; Karis K F Cheng; Ying Yu Chui; Justin McReynolds; Tony Shu Kam Mok; Winnie K W So; Wilson Tam; Connie Wong; Donna L Berry
Piloting electronic self report symptom assessment - Cancer (ESRA-C) in Hong Kong: a mixed method approach.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2011;15(4):325-34.
2011: Masahiro Fukuoka; Haiyi Jiang; Swan-Swan Leong; Alison A Armour; Tsu-Yi Chao; Da-Tong Chu; Emma L Duffield; Kazuhiko Nakagawa; Yuri Rukazenkov; Nagahiro Saijo; Georgina Speake; Virote Sriuranpong; Patrapim Sunpaweravong; Sumitra Thongprasert; Ka-Fai To; Yi-Long Wu; James Chih-Hsin Yang; Tony Shu Kam Mok
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(21):2866-74.
2011: Zhi-Jie Wang; Mei-Na Wu; Lu Yang; Ping Yang; Jun Zhao; Tong-Tong An; Hua Bai; Jian-Chun Duan; Ping-Ping Li; Tony Shu Kam Mok; Hong Sun; Yu-Yan Wang; Jie Wang
Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung CANCER.
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2011;23(2):112-7.
2011: Tony Shu Kam Mok; Te-Chun Hsia; Chun-Ming Tsai; Kenneth Tsang; Gee-Chen Chang; John Wen-Cheng Chang; Sirisinha Thitiya; Virote Sriuranpong; Sumitra Thongprasert; Daniel T T Chua; Nicola Moore; Thitiya Sirisinha; Christian Manegold
Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial.
Asia-Pacific journal of clinical oncology 2011;7 Suppl 2():4-12.
2011: Tony Shu Kam Mok
Bevacizumab in the treatment of non-small cell lung cancer: focus on East Asia.
Asia-Pacific journal of clinical oncology 2011;7 Suppl 2():1-3.
2011: Ross Soo; Dan G Tenen; Wee-Lee Yeo; Byoung-Chul Cho; Marie Loh; Tony Shu Kam Mok; Sai-Hong I Ou; Richie Soong
Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(6):1030-8.
2011: Winnie Wing-Man Leung; Suzanne C Ho; Henry L Y Chan; Vincent Wong; Winnie Yeo; Tony Shu Kam Mok
Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.
Journal of epidemiology and community health 2011;65(6):556-8.
2011: Tony Shu Kam Mok; Kwok Chi Lam
The diverse diversity.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(5):842-3.
2011: Young Joo Lee; Joo-Hang Kim; Se Kyu Kim; Sang-Jun Ha; Tony Shu Kam Mok; Tetsuya Mitsudomi; Byoung Chul Cho
Lung cancer in never smokers: change of a mindset in the molecular era.
Lung cancer (Amsterdam, Netherlands) 2011;72(1):9-15.
2011: Cesare Gridelli; Filippo De Marinis; Massimo Di Maio; D Cortinovis; F Cappuzzo; Tony Shu Kam Mok
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues.
Lung cancer (Amsterdam, Netherlands) 2011;72(1):3-8.
2011: V W Y Lui; E Y L Wong; K Ho; Patrick kwok-shing Ng; C P Y Lau; S K W Tsui; C-M Tsang; Sai Wah Tsao; S H Cheng; M H L Ng; Y K Ng; E K Y Lam; B Hong; Kwok-Wai Lo; Tony Shu Kam Mok; A T C Chan; G B Mills
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.
Oncogene 2011;30(9):1127-34.
2011: Kwok-Sui Leung; Kin Hong Lee; Jin-Feng Wang; Eddie Y T Ng; Henry L Y Chan; Stephen K W Tsui; Tony Shu Kam Mok; Pete Chi-Hang Tse; Joseph Jao-Yiu Sung
Data mining on DNA sequences of hepatitis B virus.
IEEE/ACM transactions on computational biology and bioinformatics / IEEE, ACM 2011;8(2):428-40.
2011: Cesare Gridelli; Filippo De Marinis; Massimo Di Maio; D Cortinovis; F Cappuzzo; Tony Shu Kam Mok
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.
Lung cancer (Amsterdam, Netherlands) 2011;71(3):249-57.
2011: Stephen Lam Chan; Frankie K F Mo; Philip J Johnson; Giok S Liem; Tung C Chan; Ming C Poon; Brigette B Y Ma; Thomas W T Leung; Paul B S Lai; Anthony T C Chan; Tony Shu Kam Mok; Winnie Yeo
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Journal of gastroenterology and hepatology 2011;26(2):340-7.
2011: R-Y Huang; M-Y Li; M K Y Hsin; M J Underwood; L T Ma; Tony Shu Kam Mok; T D Warner; G G Chen
4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
Oncogene 2011;30(1):106-16.
2011: Yi-Long Wu; James Chih-Hsin Yang; Guy Ely; Keunchil Park; Ross A Soo; Yan Sun; Karin Tyroller; David Wages; Tony Shu Kam Mok
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer.
BMC cancer 2011;11():430.
2011: Martin Reck; Tony Shu Kam Mok; Jürgen Wolf; David Heigener; Yi-long Wu
Reviewing the safety of erlotinib in non-small cell lung cancer.
Expert opinion on drug safety 2011;10(1):147-57.
2011: Bruma Fu; L-K Hung; Y-W Lee; Tony Shu Kam Mok; K-M Chan
Tendon adhesion measured by a video-assisted gliding test in a chicken model.
The Journal of hand surgery, European volume 2011;36(1):40-7.
2011: Kwok-Chi Lam; Tony Shu Kam Mok
Targeted therapy: an evolving world of lung cancer.
Respirology (Carlton, Vic.) 2011;16(1):13-21.
2010: Kin Chung Leung; Ming-Yue Li; Billy C S Leung; Michael K Y Hsin; Tony Shu Kam Mok; Malcolm J Underwood; George G Chen
Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB.
Experimental cell research 2010;316(20):3468-77.
2010: Ming-Yue Li; Jackie Leung; Angel W Y Kong; Nian-Ci Liang; Kefeng Wu; Michael K Y Hsin; Yi Feng Deng; Xianling Gong; Yingnian Lv; Tony Shu Kam Mok; Malcolm J Underwood; George G Chen
Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells.
Journal of molecular medicine (Berlin, Germany) 2010;88(12):1265-76.
2010: Tony Shu Kam Mok; Qing Zhou; Linda Leung; Herbert Loong
Personalized medicine for non-small-cell lung cancer.
Expert review of anticancer therapy 2010;10(10):1601-11.
2010: Tony Shu Kam Mok; Yi-long Wu; Joseph Siu-kie Au; Caicun Zhou; Li Zhang; Reury-Perng Perng; Keunchil Park
Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(10):1609-15.
2010: M M Moore; M Stockler; R Lim; Tony Shu Kam Mok; M Millward; M J Boyer
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group.
Cancer chemotherapy and pharmacology 2010;66(5):845-50.
2010: Nagahiro Saijo; Masahiro Fukuoka; Sumitra Thongprasert; Yukito Ichinose; Tetsuya Mitsudomi; Tony Shu Kam Mok; Yuichiro Ohe; Keunchil Park; Yi-Long Wu
Lung cancer working group report.
Japanese journal of clinical oncology 2010;40 Suppl 1():i7-12.
2010: Chia-Chi Lin; Hsin-Hsin Hsu; Chia-Tung Sun; Jin-Yuan Shih; Zhong-Zhe Lin; Chong-Jen Yu; George G Chen; Michael Kuan Yew Hsin; Kwok Chi Lam; Linda Leung; Chih-Hsin Yang; Tony Shu Kam Mok
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(9):1424-9.
2010: Fred R Hirsch; Tony Shu Kam Mok; Virginia Borges; Paul A Bunn
Molecularly targeted therapy: when to stop and when to continue?
The lancet oncology 2010;11(8):709-11.
2010: Stephen Lam Chan; Tony Shu Kam Mok
PARP inhibition in BRCA-mutated breast and ovarian cancers.
Lancet 2010;376(9737):211-3.
2010: Edwin P Hui; L K S Leung; F Mo; V T C Chan; A T W Ma; A Poon; Eadaoin K P Hui; Suzanne S S Mak; M Lai; K I K Lei; B B Y Ma; Tony Shu Kam Mok; Winnie Yeo; Benny Zee; A T C Chan
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong.
Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 2010;16 Suppl 3():34-7.
2010: Wen-Zhao Zhong; Yi-Long Wu; Xue-Ning Yang; Ai-Lin Guo; Jian Su; Xu-Chao Zhang; Dong-Lan Luo; Zhen Wang; Hua-Jun Chen; Qing Zhou; Chong-rui Xu; Gui-Bin Qiao; Ri-Qiang Liao; Jin-Ji Yang; Tony Shu Kam Mok
Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Clinical lung cancer 2010;11(3):160-8.
2010: Tony Shu Kam Mok
A target or a demi-target.
Clinical lung cancer 2010;11(3):147-8.
2010: Huiling Yuan; Ming-Yue Li; Lily T Ma; Michael K Y Hsin; Tony Shu Kam Mok; Malcolm J Underwood; George G Chen
15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
Thorax 2010;65(4):321-6.
2010: Vincent Wai-Sun Wong; Stephen Lam Chan; Frankie Mo; Tung-Ching Chan; Herbert Loong; Grace Lai-Hung Wong; Yanni Yan-Ni Lui; Anthony Tak-Cheung Chan; Joseph Jao-Yiu Sung; Winnie Yeo; Henry Lik-Yuen Chan; Tony Shu Kam Mok
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1660-5.
2010: Jean-Yves Douillard; Frances A Shepherd; Vera Hirsh; Tony Shu Kam Mok; Mark A Socinski; Radj Gervais; Mei-Lin Liao; Helge Bischoff; Martin Reck; Mark V Sellers; Claire L Watkins; Georgina Speake; Alison A Armour; Edward S Kim
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):744-52.
2010: Alexa B Turke; Kreshnik Zejnullahu; Yi-Long Wu; Youngchul Song; Dora Dias-Santagata; Eugene Lifshits; Luca Toschi; Andrew Rogers; Tony Shu Kam Mok; Lecia Sequist; Neal Lindeman; Carly Murphy; Sara Akhavanfard; Beow Y Yeap; Yun Xiao; Marzia Capelletti; A John Iafrate; Charles Lee; James G Christensen; Jeffrey A Engelman; Pasi A Janne
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.
Cancer cell 2010;17(1):77-88.
2010: Tony Shu Kam Mok
Living with imperfection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(2):191-2.
2010: Brigette By Ma; Edwin P Hui; Tony Shu Kam Mok
Population-based differences in treatment outcome following anticancer drug therapies.
The lancet oncology 2010;11(1):75-84.
2010: Luis Paz-Ares; Denis Soulières; Ivan Melezínek; Joachim Moecks; Lorenz Keil; Tony Shu Kam Mok; Rafael Rosell; Barbara Klughammer
Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis.
Journal of cellular and molecular medicine 2010;14(1-2):51-69.
2010: Rebecca Wing-Yan Chan; John Wong; Henry L Y Chan; Tony Shu Kam Mok; Wyatt Y W Lo; Vincent Lee; Ka F To; Paul B S Lai; Timothy H Rainer; Y M Dennis Lo; Rossa W K Chiu
Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies.
Clinical chemistry 2010;56(1):82-9.
2010: Ming-Yue Li; Michael K Y Hsin; Johnson Yip; Tony Shu Kam Mok; Malcolm J Underwood; George G Chen
PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
American journal of respiratory cell and molecular biology 2010;42(1):113-22.
2009: Tony Shu Kam Mok; Yi-Long Wu; Li Zhang
A small step towards personalized medicine for non-small cell lung cancer.
Discovery medicine 2009;8(43):227-31.
2009: Hua-Jun Chen; Tony Shu Kam Mok; Zhi-Hong Chen; Ai-Lin Guo; Xu-Chao Zhang; Jian Su; Yi-Long Wu
Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.
Pathology oncology research : POR 2009;15(4):651-8.
2009: Tony Shu Kam Mok; Suresh S Ramalingam
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.
Cancer 2009;115(22):5143-54.
2009: Ross Soo; Benjamin O Anderson; Byoung Chul Cho; Chih-Hsin Yang; Meilin Liao; Wan-Teck Lim; Peter Goldstraw; Tony Shu Kam Mok
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
The lancet oncology 2009;10(11):1102-10.
2009: Tony Shu Kam Mok; Yi-Long Wu; Chong-Jen Yu; Caicun Zhou; Yuh-Min Chen; Li Zhang; Jorge Ignacio; Meilin Liao; Vichien Srimuninnimit; Michael J Boyer; Marina Chua-Tan; Virote Sriuranpong; Aru W Sudoyo; Kate Jin; Michael Johnston; Winsome Chui; Jin-Soo Lee
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5080-7.
2009: Kin Chung Leung; Michael K Y Hsin; Joey S Y Chan; Johnson H Y Yip; Mingyue Li; Billy C S Leung; Tony Shu Kam Mok; Timothy D Warner; Malcolm J Underwood; George G Chen
Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27.
Experimental cell research 2009;315(17):2974-81.
2009: Tony Shu Kam Mok; Yi-Long Wu; Sumitra Thongprasert; Chih-Hsin Yang; Da-Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin-Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L Duffield; Claire L Watkins; Alison A Armour; Masahiro Fukuoka
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
The New England journal of medicine 2009;361(10):947-57.
2009: Yu Wang; Jisheng Li; Yan Cui; Ting Li; Ka Man Ng; Hua Geng; Henan Li; Xingsheng Shu; Hongyu Li; Wei Liu; Bing Luo; Qian Zhang; Tony Shu Kam Mok; Wei Zheng; Xiaoyan Qiu; Gopesh Srivastava; Jun Yu; Joseph J Y Sung; Anthony T C Chan; Dalong Ma; Qian Tao; Wenling Han
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Cancer research 2009;69(12):5194-201.
2009: Hatem A Azim; Inas Elattar; Fausto R Loberiza; Hatem Azim; Tony Shu Kam Mok; Apar Kishor Ganti
Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.
Lung cancer (Amsterdam, Netherlands) 2009;64(2):194-8.
2009: Tony K F Yung; Allen Chan; Tony Shu Kam Mok; Joanna Tong; Ka-Fai To; Y M Dennis Lo
Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2076-84.
2009: Winnie Yeo; Tung C Chan; Nancy Wai-Yee Leung; Wai-Yip Lam; Frankie Mo; Miu Ting Chu; Henry L Y Chan; Edwin P Hui; Kenny I K Lei; Tony Shu Kam Mok; Paul K S Chan
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):605-11.
2009: Winnie Yeo; Frankie Mo; J J S Suen; Wing M Ho; Stephen Lam Chan; W Lau; J Koh; W K Yeung; Wing H Kwan; K K C Lee; Tony Shu Kam Mok; A N Y Poon; Kwok C Lam; E K Hui; Benny Zee
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Breast cancer research and treatment 2009;113(3):529-35.
2009: Stephen Lam Chan; Frankie Mo; Philip J Johnson; Edwin P Hui; Brigette B Y Ma; Wing M Ho; Kwok C Lam; Anthony T C Chan; Tony Shu Kam Mok; Winnie Yeo
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):446-52.
2008: Rong Li; She-Juan An; Zhi-Hong Chen; Guo-Chun Zhang; Jian-Quan Zhu; Qiang Nie; Zhi Xie; Ai-Lin Guo; Tony Shu Kam Mok; Yi-Long Wu
Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Human pathology 2008;39(12):1792-801.
2008: Edward S Kim; Vera Hirsh; Tony Shu Kam Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; Long-yun Li; Claire L Watkins; Mark V Sellers; Elizabeth S Lowe; Yan Sun; Mei-Lin Liao; Kell Osterlind; Martin Reck; Alison A Armour; Frances A Shepherd; Scott M Lippman; Jean-Yves Douillard
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
Lancet 2008;372(9652):1809-18.
2008: M-Y Li; J Yip; M K Y Hsin; Tony Shu Kam Mok; Y Wu; M J Underwood; G G Chen
Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis.
The European respiratory journal 2008;32(4):911-23.
2008: Allen Chan; Paul B S Lai; Tony Shu Kam Mok; Henry L Y Chan; Chunming Ding; S W Yeung; Y M Dennis Lo
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
Clinical chemistry 2008;54(9):1528-36.
2008: Jian-quan Zhu; Wen-zhao Zhong; Guo-chun Zhang; Rong Li; Xu-Chao Zhang; Ai-lin Guo; Yi-fang Zhang; She-Juan An; Tony Shu Kam Mok; Yi-long Wu
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals.
Cancer letters 2008;265(2):307-17.
2008: Hatem Azim; Tony Shu Kam Mok
Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients' survival and quality of life.
Anti-cancer drugs 2008;19(6):645-53.
2008: Brigette Ma; Edwin P Hui; Ann King; K F To; Frankie Mo; Sing F Leung; Michael Kam; Y M Dennis Lo; Benny Zee; Tony Shu Kam Mok; Anil Ahuja; Anthony T C Chan
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy.
Cancer chemotherapy and pharmacology 2008;62(1):59-64.
2008: Joseph J Y Sung; Stephen K W Tsui; Chi-Hang Tse; Eddie Y T Ng; Kwok-Sui Leung; Kin-Hong Lee; Tony Shu Kam Mok; Angeline Bartholomeusz; Thomas C C Au; Kelvin K F Tsoi; Stephen Locarnini; Henry Lik-Yuen Chan
Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.
Journal of virology 2008;82(7):3604-11.
2008: Brigette Ma; Boon Cher Goh; Eng Huat Tan; Kwok Chi Lam; Ross Soo; Swan-Swan Leong; Ling Zhi Wang; Frankie Mo; Anthony T C Chan; Benny Zee; Tony Shu Kam Mok
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells.
Investigational new drugs 2008;26(2):169-73.
2008: Simon C H Yu; Thomas W T Leung; Wan Yee Lau; Nelson Lee; Edwin P Hui; Winnie Yeo; Paul B S Lai; Tony Shu Kam Mok
A comparison of three transarterial lipiodol-based formulations for hepatocellular carcinoma: in vivo biodistribution study in humans.
Cardiovascular and interventional radiology 2008;31(2):289-98.
2008: Tony Shu Kam Mok; John Crowley
Big question, small answer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):105-6.
2008: George G Chen; Tak Wai Lee; Hu Xu; Johnson H Y Yip; Mingyue Li; Tony Shu Kam Mok; Anthony P C Yim
Increased inducible nitric oxide synthase in lung carcinoma of smokers.
Cancer 2008;112(2):372-81.
2008: Henry Lik-Yuen Chan; Chi-Hang Tse; Frankie Mo; Jane Koh; Vincent Wong; Grace Lai-Hung Wong; Stephen Lam Chan; Winnie Yeo; Joseph Jao-Yiu Sung; Tony Shu Kam Mok
High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):177-82.
2008: Simon C H Yu; Edwin P Hui; John Wong; Herman Wong; Frankie Mo; Simon S M Ho; Yuen Y Wong; Winnie Yeo; Paul B S Lai; Anthony T C Chan; Tony Shu Kam Mok
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.
Journal of vascular and interventional radiology : JVIR 2008;19(1):95-103.
2007: Qiang Nie; Zhen Wang; Guo-Chun Zhang; She-Juan An; Jia-Yin Lin; Ai-Lin Guo; Rong Li; Bin Gan; Ying Huang; Tony Shu Kam Mok; Yi-Long Wu
The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib.
European journal of pharmacology 2007;570(1-3):175-81.
2007: Tony Shu Kam Mok; Simon Ho; Gong Chan; Wing-Ming Ho; Herman Wong; Anthony T C Chan; Winnie Yeo; Anthony P C Yim; Karen Chak; Yolanda Lee; Kwok C Lam
Sequential chemotherapy with combination irinotecan and cisplatin followed by docetaxel for treatment-naïve patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(9):838-44.
2007: She-Juan An; Qiang Nie; Zhi-Hong Chen; Qiu-xiong Lin; Zhen Wang; Zhi Xie; Shi-Liang Chen; Ying Huang; Ai-Ye Zhang; Jin-Feng Yan; Hong-Sui Wu; Jia-Ying Lin; Rong Li; Xu-Chao Zhang; Ai-Lin Guo; Tony Shu Kam Mok; Yi-Long Wu
KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer.
Journal of cancer research and clinical oncology 2007;133(9):635-42.
2007: Raymond Hang Wun Li; Wing Hung Tam; Pak C Ng; Tony Shu Kam Mok; Barbara Tam; tze lau
Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report.
The Journal of reproductive medicine 2007;52(6):575-6.
2007: Winnie Yeo; Frankie Mo; Stephen Lam Chan; Nancy Wai-Yee Leung; Pun Hui; Wai-Yip Lam; Tony Shu Kam Mok; Kwok C Lam; Wing M Ho; Jane Koh; Julian W Tang; Anthony T C Chan; Paul K S Chan
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.
Hepatology (Baltimore, Md.) 2007;45(6):1382-9.
2007: Jeffrey A Engelman; Kreshnik Zejnullahu; Tetsuya Mitsudomi; Youngchul Song; Courtney Hyland; Joon Oh Park; Neal Lindeman; Christopher-Michael Gale; Xiaojun Zhao; James Christensen; Takayuki Kosaka; Alison J Holmes; Andrew M Rogers; Federico Cappuzzo; Tony Shu Kam Mok; Charles Lee; Bruce E Johnson; Lewis C Cantley; Pasi A Janne
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Science (New York, N.Y.) 2007;316(5827):1039-43.
2007: Yi-Long Wu; Wen-Zhao Zhong; Long-yun Li; Xiao-tong Zhang; Li Zhang; Cai-cun Zhou; Wei Liu; Bin Jiang; Xin-lin Mu; Jia-Ying Lin; Qing Zhou; Chong-rui Xu; Zhen Wang; Guo-Cai Zhang; Tony Shu Kam Mok
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5):430-9.
2007: Tony Shu Kam Mok; Winnie Yeo; Philip J Johnson; Pun Hui; Wing M Ho; Kwok C Lam; M Xu; Karen Chak; A Chan; H Wong; Frankie Mo; Benny Zee
A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):768-74.
2007: Sui-Man Tse; Yong Liang; Kwok-Sui Leung; Kin-Hong Lee; Tony Shu Kam Mok
A memetic algorithm for multiple-drug cancer chemotherapy schedule optimization.
IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society 2007;37(1):84-91.
2006: Mingyue Li; Tak W Lee; Anthony P C Yim; Tony Shu Kam Mok; George G Chen
Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Journal of cellular physiology 2006;209(2):428-38.
2006: Winnie Yeo; Frankie Mo; J Koh; Anthony T C Chan; T Leung; Pun Hui; Stephen Lam Chan; A Tang; J J Lee; Tony Shu Kam Mok; Paul B S Lai; Philip J Johnson; Benny Zee
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1083-9.
2006: Yong Liang; Kwok-Sui Leung; Tony Shu Kam Mok
A novel evolutionary drug scheduling model in cancer chemotherapy.
IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society 2006;10(2):237-45.
2006: George G Chen; Tak W Lee; Johnson H Y Yip; Hu Xu; Isa K Y Lee; Tony Shu Kam Mok; Timothy D Warner; Anthony P C Yim
Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.
Cancer letters 2006;234(2):193-8.
2006: Raymond P Abratt; Jung Sin Lee; Ji Youn Han; Chun-Ming Tsai; Michael Boyer; Tony Shu Kam Mok; Sang-We Kim; Jung Sin Lee; Alan J M Brnabic; William H H Reece; Manfred Lehnert
Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(2):135-40.
2006: Tony Shu Kam Mok; Eve Choi; Daisy Yau; Anandhi Johri; Winnie Yeo; Anthony T C Chan; Cesar Wong
Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study.
Oncology 2006;71(3-4):292-6.
2005: Terence C W Poon; Clarissa H S Chiu; Paul B S Lai; Tony Shu Kam Mok; Benny Zee; Anthony T C Chan; Joseph J Y Sung; Philip J Johnson
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(42):6701-6.
2005: Tony Shu Kam Mok; Winnie Yeo; Simon Yu; Paul Lai; Henry Lik-Yuen Chan; Anthony T C Chan; Joseph W Y Lau; Herman Wong; Nancy Leung; Edwin P Hui; Joseph Sung; Jane Koh; Frankie Mo; Benny Zee; Philip J Johnson
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8041-7.
2005: Mingyue Li; Tak W Lee; Tony Shu Kam Mok; Timothy D Warner; Anthony P C Yim; George G Chen
Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Journal of cellular biochemistry 2005;96(4):760-74.
2005: Winnie Yeo; Tony Shu Kam Mok; Benny Zee; Thomas W T Leung; Paul B S Lai; Wan Y Lau; Jane Koh; Frankie Mo; Simon C H Yu; Anthony T C Chan; Pun Hui; Brigette Ma; Kwok C Lam; Wing M Ho; Herman T Wong; Amanda Tang; Philip J Johnson
A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
Journal of the National Cancer Institute 2005;97(20):1532-8.
2005: Juan C Garzon; Fernand Mac-Moune Lai; Tony Shu Kam Mok; Anthony V Manlulu; Calvin S H Ng; Tak Wai Lee; Anthony P C Yim
Clear cell carcinoma of the lung revisited.
The Journal of thoracic and cardiovascular surgery 2005;130(4):1198-9.
2005: Miquel Taron; Yukito Ichinose; Rafael Rosell; Tony Shu Kam Mok; Bartomeu Massuti; Lurdes Zamora; José-Luis Mate; Christian Manegold; Mayumi Ono; Cristina Queralt; Thierry jahan; Jose Javier Sanchez; Maria Sanchez-Ronco; Victor Hsue; David M Jablons; Jose Miguel Sanchez; Teresa Moran
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5878-85.
2005: Winnie Yeo; Edwin P Hui; Anthony T C Chan; Wing M Ho; Kwok C Lam; Paul K S Chan; Tony Shu Kam Mok; Jam J Lee; Frankie Mo; Philip J Johnson
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
American journal of clinical oncology 2005;28(4):379-84.
2005: Anthony T C Chan; Sing-Fai Leung; Roger K C Ngan; Peter M L Teo; Wai-Hon Lau; W H Kwan; Edwin P Hui; H Y Yiu; Winnie Yeo; FY Cheung; Kwok Hung Yu; K W Chiu; D T Chan; Tony Shu Kam Mok; Stephen Yau; Kam-Tong Yuen; Frankie Mo; Maria M P Lai; Brigette B Y Ma; Michael K M Kam; Thomas W T Leung; Philip J Johnson; Peter H K Choi; Benny Zee
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.
Journal of the National Cancer Institute 2005;97(7):536-9.
2005: Wing M Ho; Brigette Ma; Tony Shu Kam Mok; Winnie Yeo; Paul Lai; R Lim; Jane Koh; Y Y Wong; Ann King; C K Leow; Anthony T C Chan
Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group.
Medical oncology (Northwood, London, England) 2005;22(3):303-12.
2005: Tony Shu Kam Mok; Kwok C Lam; Conrad Lee; Li Zhang; Herman Wong; Anthony T C Chan; Winnie Yeo; Anthony P C Yim; Karen Chak; Benny Zee
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
Oncology 2005;68(4-6):485-92.
2005: Margaret S-T Chua; Tony Shu Kam Mok; Wing H Kwan; Winnie Yeo; Benny Zee
Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management.
The breast journal 2005;11(1):52-6.
2004: Winnie Yeo; Kwok C Lam; Benny Zee; P S K Chan; Frankie Mo; Wing M Ho; Wai-Lap Wong; Thomas W T Leung; Anthony T C Chan; Brigette Ma; Tony Shu Kam Mok; Philip J Johnson
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(11):1661-6.
2004: Tony Shu Kam Mok
A new horizon of targeted therapy in management of lung cancer.
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2004;7(4):276-83.
2004: Benny Chung-Ying Zee; Tony Shu Kam Mok
Methodology for quality-of-life assessment: a critical appraisal.
Thoracic surgery clinics 2004;14(3):305-15.
2004: Shirley M-H Sy; Boli Fan; Tak Wai Lee; Tony Shu Kam Mok; Elizabeth Pang; Anthony Yim; Nathalie Wong
Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers.
Cancer genetics and cytogenetics 2004;153(1):57-9.
2004: Anthony T C Chan; Brigette B Y Ma; Y M Dennis Lo; Sing-Fai Leung; Wing H Kwan; Edwin P Hui; Tony Shu Kam Mok; Michael K M Kam; Lisa S Chan; Samuel K W Chiu; Kwok Hung Yu; Kin-yin Cheung; Karen Lai; Maria Lai; Frankie Mo; Winnie Yeo; Ann King; Philip J Johnson; Peter M L Teo; Benny Zee
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3053-60.
2004: Tony Shu Kam Mok; Simon C H Yu; Conrad Lee; Joseph Sung; Nancy Leung; Paul Lai; Thomas W T Leung; Anthony T C Chan; Winnie Yeo; Jane Koh; Philip Johnson
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
AJR. American journal of roentgenology 2004;183(2):453-8.
2004: Shirley M-H Sy; Nathalie Wong; Tak Wai Lee; G Tse; Tony Shu Kam Mok; B Fan; Elizabeth Pang; Philip J Johnson; A Yim
Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.
European journal of cancer (Oxford, England : 1990) 2004;40(7):1082-94.
2004: Winnie Yeo; Paul K S Chan; Wing M Ho; Benny Zee; Kwok C Lam; Kenny I K Lei; Anthony T C Chan; Tony Shu Kam Mok; Jam J Lee; Thomas W T Leung; Sheng Zhong; Philip J Johnson
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):927-34.
2004: Annette N Y Poon; Simon S M Ho; Winnie Yeo; Tony Shu Kam Mok
Brain metastasis responding to gefitinib alone.
Oncology 2004;67(2):174-8.
2004: Tony Shu Kam Mok; Thomas W T Leung; Gill Brown; Chris Moyses; Anthony T C Chan; Winnie Yeo; Herman Wong; Karen Chak; Philip Johnson
A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.
Acta oncologica (Stockholm, Sweden) 2004;43(3):245-51.
2003: Edwin P Hui; Terence C W Poon; Peter M L Teo; Frankie Mo; Benny Zee; Sing-Fai Leung; Stephen Ho; Tony Shu Kam Mok; Wing H Kwan; Philip J Johnson; Anthony T C Chan
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;69(1):53-62.
2003: Shirley M-H Sy; Nathalie Wong; Tony Shu Kam Mok; Ming Tsao; Tak Wai Lee; Gary Tse; Fiona H Blackhall; Philip J Johnson; Anthony P Yim
Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):91-9.
2003: Tak W Lee; George G Chen; Hu Xu; Johnson H Y Yip; Ernest C W Chak; Tony Shu Kam Mok; Anthony P C Yim
Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1296-301.
2003: Terence C W Poon; Tai-Tung Yip; Anthony T C Chan; Christine Yip; Victor Yip; Tony Shu Kam Mok; Conrad C Y Lee; Thomas W T Leung; Stephen K W Ho; Philip J Johnson
Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.
Clinical chemistry 2003;49(5):752-60.
2003: Kwok C Lam; Winnie Yeo; Janet F Y Lee; John Chow; Tony Shu Kam Mok
Unusual abdominal tumors: case 4. Multiple lymphomatous polyposis in mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):955-6.
2003: Enders Ng; S K H Wong; Tony Shu Kam Mok; W Y Chan; S C Sydney Chung
Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2003;6(2):122-6.
2002: Tony Shu Kam Mok; Herman Wong; Benny Zee; Kwok Hung Yu; Thomas W T Leung; Tak Wai Lee; Anthony Yim; Anthony T C Chan; Winnie Yeo; Karen Chak; Philip Johnson
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Cancer 2002;95(7):1511-9.
2002: Winnie Yeo; Tony Shu Kam Mok; Kin K Tse; Wing H Kwan; Kwok C Lam; Wing M Ho; Samuel K W Chiu; Anthony T C Chan; Thomas W T Leung; Frankie Mo; Philip J Johnson
Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.
Anti-cancer drugs 2002;13(6):655-62.
2002: Terence C W Poon; Tony Shu Kam Mok; Anthony T C Chan; Charles M L Chan; Veronica Leong; Steven H T Tsui; Thomas W T Leung; Herman T M Wong; Stephen K W Ho; Philip J Johnson
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Clinical chemistry 2002;48(7):1021-7.
2002: Alexander Molassiotis; Tony Shu Kam Mok; Bernard M C Yam; Hilary P Yung
An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy.
European journal of cancer care 2002;11(2):108-13.
2002: Tony Shu Kam Mok; Benny Zee
Adequate lymph node staging is fundamental to comparative study on resectable non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2604-5; author reply 2605.
2002: Anthony T C Chan; Peter M L Teo; Roger K C Ngan; Thomas W T Leung; Wai-Hon Lau; Benny Zee; Sing-Fai Leung; FY Cheung; Winnie Yeo; Harry H Y Yiu; Kwok Hung Yu; K W Chiu; D T Chan; Tony Shu Kam Mok; Kam-Tong Yuen; Frankie Mo; Maria Lai; Wing H Kwan; P Choi; Philip J Johnson
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2038-44.
2002: Alexander Molassiotis; Hilary P Yung; Bernard M C Yam; Flora Y S Chan; Tony Shu Kam Mok
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(3):237-46.
2002: Alexander Molassiotis; Bernard M C Yam; Hilary P Yung; Flora Y S Chan; Tony Shu Kam Mok
Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(2):139-45.
2002: Calvin S H Ng; Jun Zhang; Song Wan; Tak Wai Lee; Ahmed A Arifi; Tony Shu Kam Mok; Dennis Y M Lo; Anthony P C Yim
Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer.
Journal of surgical oncology 2002;79(2):101-6.
2001: Winnie Yeo; Pun Hui; J H Chow; Tony Shu Kam Mok
Hepatocellular carcinoma and lymphoma--two hepatitis B virus-related malignant diseases.
The lancet oncology 2001;2(9):543.
2001: Tony Shu Kam Mok; S Kanekal; Xiao-rong Lin; Thomas W T Leung; Anthony T C Chan; Winnie Yeo; S Yu; Karen Chak; R Leavitt; Philip Johnson
Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
Cancer 2001;91(12):2369-77.
2001: Terence C W Poon; Anthony T C Chan; Benny Zee; Stephen K W Ho; Tony Shu Kam Mok; Thomas W T Leung; Philip J Johnson
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Oncology 2001;61(4):275-83.
2001: A T Chan; P Jacobs; W Yeo; M Lai; C B Hazlett; Tony Shu Kam Mok; T W Leung; W Y Lau; P J Johnson
The cost of palliative care for hepatocellular carcinoma in Hong Kong.
PharmacoEconomics 2001;19(9):947-53.
2000: Tony Shu Kam Mok; Benny Zee; Anthony T C Chan; Winnie Yeo; W T Yang; Anthony P C Yim; S F Leung; B Nguyen; Thomas W T Leung; P Johnson
A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.
Cancer 2000;89(3):543-50.
2000: Anil T Ahuja; Ann D King; M J Bradley; W W Yeo; Tony Shu Kam Mok; Constantine Metreweli
Sonographic findings in masseter-muscle metastases.
Journal of clinical ultrasound : JCU 2000;28(6):299-302.
2000: Tony Shu Kam Mok; W H Kwan; W M Yeo; Anthony T C Chan; E C Chan; Karen Chak; D L Chow; C Lo; Thomas W T Leung; Peter M L Teo
Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;54(3):201-8.
2000: P Zhang; W Chin; L T Chow; A S Chan; A P Yim; S F Leung; Tony Shu Kam Mok; K S Chang; P J Johnson; J Y Chan
Lack of expression for the suppressor PML in human small cell lung carcinoma.
International journal of cancer. Journal international du cancer 2000;85(5):599-605.
2000: C S Fan; N Wong; S F Leung; K F To; K W Lo; S W Lee; Tony Shu Kam Mok; Philip J Johnson; D P Huang
Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.
Human pathology 2000;31(2):169-78.
2000: T M Wong; W Yeo; L W Chan; Tony Shu Kam Mok
Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature.
Gynecologic oncology 2000;76(2):223-5.
1999: Winnie Yeo; JL Steinberg; John S Tam; Paul K S Chan; Nancy Wai-Yee Leung; Kwok C Lam; Tony Shu Kam Mok; Philip J Johnson
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
Journal of medical virology 1999;59(3):263-9.
1999: Thomas W T Leung; Y Z Patt; Wan Yee Lau; Stephen K W Ho; Simon C H Yu; Anthony T C Chan; Tony Shu Kam Mok; Winnie Yeo; C T Liew; Nancy Wai-Yee Leung; Amanda M Y Tang; Philip J Johnson
Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1676-81.
1999: Wan Yee Lau; Thomas W T Leung; Stephen K W Ho; M Chan; D Machin; J Lau; Anthony T C Chan; Winnie Yeo; Tony Shu Kam Mok; Simon C H Yu; Nancy Wai-Yee Leung; P J Johnson
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
Lancet 1999;353(9155):797-801.
1999: Tony Shu Kam Mok; Thomas W T Leung; S D Lee; Y Chao; Anthony T C Chan; A Huang; M C Lui; Winnie Yeo; Karen Chak; A Johnston; Philip Johnson
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 1999;44(4):307-11.
1998: Winnie Yeo; Thomas W T Leung; Anthony T C Chan; Samuel K W Chiu; P Yu; Tony Shu Kam Mok; Philip J Johnson
A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2027-31.
1998: Anthony T C Chan; Peter M L Teo; Kwok C Lam; W Y Chan; J H Chow; Anthony P C Yim; Tony Shu Kam Mok; Wing H Kwan; Thomas W T Leung; Philip J Johnson
Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.
Cancer 1998;83(5):925-9.
1998: Tony Shu Kam Mok; J Steinberg; Anthony T C Chan; W M Yeo; P Hui; Thomas W T Leung; Philip Johnson
Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.
Cancer 1998;82(12):2439-48.
1998: Anthony T C Chan; Thomas W T Leung; W H Kwan; Tony Shu Kam Mok; Winnie Yeo; M Lai; Philip J Johnson
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.
Cancer chemotherapy and pharmacology 1998;42(3):247-9.
1997: Tony Shu Kam Mok; A P Koehler; M Y Yu; D H Ellis; Philip J Johnson; N W Wickham
Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia.
Journal of clinical microbiology 1997;35(10):2654-6.
1997: Tony Shu Kam Mok
Autologous bone marrow transplantation versus MACOP-B in B-cell lymphoma.
The New England journal of medicine 1997;337(10):711; author reply 711-2.